Notas de prensa

  • 15 de noviembre de 2005
  • 168

Amgen Foundation Donates $500,000 to South Asia Earthquake Relief Efforts

Foundation Encourages Other Corporations, Philanthropies to Contribute THOUSAND OAKS, CA. (November 15, 2005) - The Amgen Foundation today announced that it will provide $500,000 in cash donations to aid victims of the October 8 South Asia earthquake. The Foundation will donate $250,000 to Oxfam International to help provide appropriate winter shelter and clothing for earthquake survivors throughout Pakistan and India. The Foundation will also give $250,000 to Direct Relief International for medical equipment and supplies urgently needed in the impacted region. "Amgen extends its deepest sympathies to those impacted by the tragedy of the South Asia earthquakes," said Jean Lim, president of the Amgen Foundation. "With millions now homeless and winter approaching, the need for support is critical." In addition to the Oxfam and Direct Relief International support, the Foundation said it is using its Matching Gifts Program to match dollar-for-dollar the earthquake relief donations made by individual Amgen staff members. "The business community has given generously over the past year to support disaster victims worldwide," Lim said. "Once again significant assistance is required, and we encourage other companies to join us in supporting the relief effort to the fullest extent possible." About the Amgen Foundation The Amgen Foundation (www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $53 million in grants to local, regional and national non-profit organizations that impact society in inspiring and innovative ways. It has also supported disaster relief efforts both domestically and internationally. Contact: Amgen, Thousand Oaks Mary Klem, (805) 447-4587 (media) Arvind Sood, (805) 447-1060 (investors)

Destacadas

  • Se presenta el primer análisis provisional del estudio PROSPER con mogamulizumab en pacientes con LCCT

    Ariana del Río García

    Se presenta el primer análisis provisional del estudio PROSPER con mogamulizumab en pacientes con LCCT

    Leer más
  • Roche revela su última innovación para la monitorización continua de glucosa (MCG) con capacidades predictivas en el 35º Congreso de la Sociedad Española de Diabetes (SED)

    Verónica SF

    Roche revela su última innovación para la monitorización continua de glucosa (MCG) con capacidades predictivas en el 35º Congreso de la Sociedad Española de Diabetes (SED)

    Leer más
  • Investigadores de Pangaea Lab innovan en biopsia líquida al usar líquidos pleurales para el estudio molecular y a la vez generar cultivos celulares para analizar la respuesta del cáncer gástrico y de páncreas a fármacos

    Patricia Morén

    Investigadores de Pangaea Lab innovan en biopsia líquida al usar líquidos pleurales para el estudio molecular y a la vez generar cultivos celulares para analizar la respuesta del cáncer gástrico y de páncreas a fármacos

    Leer más

Newsletter

Suscríbete para conocer las novedades del mundo farmacéutico y sanitario.

¿Qué es?

FarmaNews pone a disposición de los medios y departamentos de comunicación, un canal para publicar notas de prensa y convocatorias del mundo sanitario y farmacéutico.

Contacto

C/ Pau Clarís, 21, local 2
08780, Pallejà, Barcelona